These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12831505)

  • 1. Hepatic biotransformation of the new calcium-mimetic agent, RWJ-68025, in the rat and in man--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Rybczynski PJ; Demarest K
    J Pharm Pharmacol; 2003 May; 55(5):631-7. PubMed ID: 12831505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro metabolism of the new anxiolytic agent, RWJ-50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp.
    Wu WN; McKown LA; Melton JL; Reitz AB
    J Pharm Pharmacol; 2003 Aug; 55(8):1099-105. PubMed ID: 12956899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro biotransformation of the analgesic agent, RWJ-51784, in rat, dog and human.
    Wu WN; McKown LA; Carson JR
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):107-11. PubMed ID: 12877567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    J Pharm Biomed Anal; 2003 Feb; 31(1):95-102. PubMed ID: 12560053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites.
    Wu WN; McKown LA; Moyer MD; Reitz AB
    J Pharm Biomed Anal; 2000 Dec; 24(2):307-16. PubMed ID: 11130209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human hepatic metabolism of the anxiolytic agent, RWJ-51521--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):257-62. PubMed ID: 15726887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metabolism of the analgesic agent, RWJ-37874, in rat and human.
    Wu WN; McKown LA; Carson JR
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):101-5. PubMed ID: 12877566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the new alpha-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):113-20. PubMed ID: 16010870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry.
    Wu WN; McKown LA; Gopaul VS
    J Pharm Pharmacol; 2004 Jun; 56(6):749-55. PubMed ID: 15231040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the new nonbenzodiazepine anxiolytic agent, RWJ-51204, in mouse, rat, dog, monkey and human hepatic S9 fractions, and in rats, dogs and humans.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2004; 29(4):263-8. PubMed ID: 15726888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro metabolism of thalicarpine, an aporphine-benzyltetrahydroisoquinoline alkaloid, in the rat. API-MS/MS identification of thalicarpine and metabolites.
    Wu WN; McKown LA
    J Pharm Biomed Anal; 2002 Aug; 30(1):141-50. PubMed ID: 12151074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the alpha-1A-adrenergic receptor antagonist, pyridine-phenylpiperazine analog (RWJ-69597), in rat, dog and human hepatic S9 fractions -API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):105-11. PubMed ID: 16010869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat--API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):279-86. PubMed ID: 14743969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
    Wu WN; Masucci JA; Caldwell GW; Carson JR
    Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of a new P-glycoprotein inhibitor HM-30181 in rats using liquid chromatography/electrospray mass spectrometry.
    Paek IB; Ji HY; Kim MS; Lee G; Lee HS
    Rapid Commun Mass Spectrom; 2006; 20(9):1457-62. PubMed ID: 16586459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of mifepristone (RU-486) in rat, monkey and human hepatic S9 fractions: identification of three new mifepristone metabolites.
    Wu WN; McKown LA; Moyer MD; Johannsen TB; Takacs AR
    Xenobiotica; 1999 Nov; 29(11):1089-100. PubMed ID: 10598744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.